Skip to content

Evaluation of two alpha-tocopherol capsules effect on maternal and child vitamin E levels

Supplementation with alpha-tocopherol on the nutritional status in vitamin E - : Maternal Supplementation with vitamin E

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9wch5m
Enrollment
Unknown
Registered
2015-10-31
Start date
2015-06-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin E deficiency

Interventions

This study aims to evaluate what dose of maternal supplementation with alpha-tocopherol is more efficient in increasing and maintaining the alpha-tocopherol concentrations in the blood and mother's mi
Dietary supplement
SP6.051.227

Sponsors

Universidade Federal do Rio Grande do Norte (Centro Cordenador)
Lead Sponsor
Universidade Federal do Rio Grande do Norte
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Lactating women; normal delivery; term delivery; aged 18 to 40 years.

Exclusion criteria

Exclusion criteria: Women with any clinical sign of disease; infections; syphilis; HIV; gastrointestinal diseases; liver disease; heart disease; diabetes; hypertension; cancer; mental disorder; twin pregnancie; newborn with fetal malformations; history of abortion; use of antithrombotics; use of supplements containing vitamin E during pregnancy

Design outcomes

Primary

MeasureTime frame
Expected outcome: Increased alpha-tocopherol levels in blood and mother's milk after administration of supplemental vitamin E, within 60 days postpartum. For determining the expected outcome, the efficiency of the two supplementation schemes adopted in increasing and maintaining the alpha-tocopherol levels in the blood and maternal milk in the given time period will be evaluated. Will be used statistical tools to observe variation in alpha-tocopherol levels of the control group, supplemented 1 and 2 supplemented.

Secondary

MeasureTime frame
Expected outcome: increase and maintain the most significant level of vitamin E in breast milk of lactating group supplemented 2. To realize the expected outcome will be used statistical tools to compare the supplementation scheme 2 (administration of 01 400 IU capsule on the 1st and 20th days postpartum) efficiency with supplementation scheme 1 (administration of 01 400 IU capsule on the 1st day postpartum).

Countries

Brazil

Contacts

Public ContactLarissa de Lira

Universidade Federal do Rio Grande do Norte

liralq@gmail.com+55(84)991386330

Outcome results

None listed

Source: REBEC (via WHO ICTRP)